1. Home
  2. IFBD vs XBIO Comparison

IFBD vs XBIO Comparison

Compare IFBD & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Infobird Co. Ltd

IFBD

Infobird Co. Ltd

HOLD

Current Price

$0.96

Market Cap

8.4M

Sector

Technology

ML Signal

HOLD

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$3.01

Market Cap

7.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IFBD
XBIO
Founded
2001
N/A
Country
China
United States
Employees
N/A
2
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
7.5M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
IFBD
XBIO
Price
$0.96
$3.01
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
2.1K
25.0K
Earning Date
05-01-2023
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$2.81
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$1.90
52 Week High
$1.69
$13.93

Technical Indicators

Market Signals
Indicator
IFBD
XBIO
Relative Strength Index (RSI) 48.09 58.54
Support Level $0.93 $2.64
Resistance Level $1.05 $3.12
Average True Range (ATR) 0.04 0.25
MACD -0.01 0.03
Stochastic Oscillator 23.08 61.54

Price Performance

Historical Comparison
IFBD
XBIO

About IFBD Infobird Co. Ltd

Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service provider of AI-powered, or artificial intelligence-enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process, including pre-sales and sales activities, and post-sales customer support. It also offers AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performance of agents.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Share on Social Networks: